ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
0 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
9 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
2 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
2 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
1 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
1 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
1 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
6 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
0 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
18 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
17 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
2 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
COVID ARDS interim analysis
|
|
Preni
|
37 |
20K |
1 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
37
|
20K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
Preni
|
491 |
193K |
1 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
491
|
193K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
4 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Preni
|
2.3K |
905K |
10 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
2.3K
|
905K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Preni
|
17K |
6.7M |
0 |
25/07/20 |
25/07/20 |
ASX - By Stock
|
17K
|
6.7M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Preni
|
17K |
6.7M |
100 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
17K
|
6.7M
|
100
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
6 |
19/07/20 |
19/07/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
0 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
APT |
Re:
Ann: Media Releases
|
|
Preni
|
37 |
13K |
3 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
37
|
13K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
0 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Coming News ???
|
|
Preni
|
510 |
223K |
1 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
510
|
223K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
24 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
23K
|
13M
|
24
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
1 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
48 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
23K
|
13M
|
48
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
21 |
21/06/20 |
21/06/20 |
ASX - By Stock
|
23K
|
13M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Preni
|
17K |
6.7M |
11 |
20/06/20 |
20/06/20 |
ASX - By Stock
|
17K
|
6.7M
|
11
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
6 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
6 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
0 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
1 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
AFR
|
|
Preni
|
29 |
10K |
0 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
29
|
10K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
4 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
5 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease
|
|
Preni
|
143 |
71K |
13 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
143
|
71K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease
|
|
Preni
|
143 |
71K |
15 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
143
|
71K
|
15
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
2 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
7 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
10 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
0 |
26/05/20 |
26/05/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 3 Articles on RYONCIL GvHD Trial Results Published in BBMT
|
|
Preni
|
127 |
71K |
7 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
127
|
71K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
2 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Preni
|
17K |
6.7M |
2 |
17/05/20 |
17/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Competition? What Competition?
|
|
Preni
|
73 |
32K |
3 |
17/05/20 |
17/05/20 |
ASX - By Stock
|
73
|
32K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Preni
|
17K |
6.7M |
4 |
16/05/20 |
16/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Preni
|
17K |
6.7M |
8 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
5 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Preni
|
23K |
13M |
2 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Preni
|
933 |
436K |
5 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
933
|
436K
|
5
|
|